文献速递心血管PET

放射性核素影像引导的心脏修复

Radionuclide Image-Guided Repair of the Heart.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-12-18

本文综述了随着治疗策略从外源性骨髓细胞递送向药物刺激内源性修复演变,心脏修复成像也取得显著进展。无创临床成像可评估收缩功能、灌注和组织活力;直接标记细胞或新型治疗药物可显示全身分布和药代动力学;靶向分子成像剂可与靶向同一通路的药物偶联,实现分子水平时空变化探究,以炎症在心脏修复中的作用为例。影像引导修复概念为分子成像在心血管医学中开辟重要且不断发展的领域,有望预测结局、改善患者分层并推进个体化修复治疗。

要点

  • 无创临床成像可稳定定量收缩功能、灌注和组织活力,是功能结局评估的基石。
  • 直接标记细胞或新型治疗药物可显示全身分布和药代动力学,揭示滞留、靶向和药物-组织相互作用。
  • 靶向分子成像剂可与靶向同一通路的药物偶联,在分子水平探究组织变性和再生的时空变化。

核心结论

  • 影像引导修复概念为分子成像在心血管医学中开辟重要且不断发展的领域,可能预测结局、改善患者分层并推进个体化修复治疗。

研究设计与样本

  • 综述,检索范围与纳入文献未报告。

关键影像表现/征象

  • 直接标记细胞或其他新型治疗药物可显示治疗药物的全身分布和药代动力学,提供滞留、靶向和药物-组织相互作用的见解。
  • 靶向分子成像剂正在出现,可能与靶向同一通路的药物特异性偶联。

诊断标准与关键数值

  • 无创临床成像可稳定定量收缩功能、灌注和组织活力。
  • 靶向分子成像方法可在分子水平探究组织变性和再生的时空变化,有助于准确选择患者和确定治疗干预时机,近期聚焦炎症在心脏修复中作用的努力即为示例。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

As therapeutic approaches have evolved from exogenous bone marrow cell delivery to pharmacological stimulation of endogenous repair, so too has imaging of cardiac repair made significant strides forward. Evaluation of functional outcome remains a staple of noninvasive clinical imaging, which can robustly quantify contractile function, perfusion, and tissue viability. Direct labeling of cells or other novel therapeutics visualizes the whole-body distribution and pharmacokinetics of the therapeutic agent, providing insights into retention, targeting, and drug-tissue interactions. And finally, targeted molecular imaging agents are emerging that may be specifically coupled to drugs targeting the same pathway. This approach enables interrogation of temporal and spatial changes at the molecular level underlying tissue degeneration and regeneration, which facilitates accurate patient selection and timing for therapeutic intervention, as exemplified by recent efforts focusing on the role of inflammation in cardiac repair. The concept of image-guided repair carves out an important and evolving niche for molecular imaging in cardiovascular medicine, with the potential not only to predict outcomes but also to improve patient stratification and progress toward personalized reparative therapy.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Hess A, Thackeray JT, Wollert KC, et al. Radionuclide Image-Guided Repair of the Heart. JACC Cardiovasc Imaging. 2019. PMID: 31864993. doi:10.1016/j.jcmg.2019.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。